Monday, October 9, 2017

(LML) Steroid dependency in Leprosy

Leprosy Mailing List – October 8,  2017

Ref.:  (LML) Steroid dependency in Leprosy 

From:  José Augusto, Rio de Janeiro, Brazil


 

Dear Pieter,

 

 

Thank Dr. Grace Warren (LML, 2-10-2017) to bring this important topic to our attention again. The longstanding use of steroids in leprosy (and the resulting dependency) is very worrying and must be well studied and evaluated. In Brazil we have had many problems with the indiscriminate use of this therapy leading to serious side effects and facilitating the appearance of opportunistic diseases of infectious origin. The protocols recommended are in the great majority of the times not followed by the doctors.

 

I think there must be time and dosage of corticosteroids adjusted for differential use when we have cases with cutaneous involvement and when we have neurological compromise.

 

Therapeutic behavior with Clofazimine unfortunately still needs to be further studied in endemic countries. However, it should not be forgotten that it also has side effects when used in high doses for an extended time.

 

Thank you.

 

Yours,

 

 

Jose Augusto



Dr. José Augusto da Costa Nery

 

Laboratório de Hanseníase/ ASA

Instituto Oswaldo Cruz - Fiocruz

Av. Brasil 4365, Manguinhos, Rio de Janeiro - RJ CEP 21040-360 - Tels.(21)2562-1588

 

neryjac@ioc.fiocruz.br

neryjac@gmail.com


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

No comments: